Hyderabad, Oct. 21 -- Hyderabad-based Nucelion Therapeutics Pvt. Ltd. ("Nucelion"), a subsidiary of Bharat Biotech, a specialised cell and gene therapy Contract Research, Development, and Manufacturing Organisation (CRDMO), and VeGen Bio Pvt. Ltd. ("VeGen Bio" / "VeGen Labs"), a Hyderabad-based precision oncology company, today announced a strategic collaboration for the technology transfer, clinical manufacturing, and commercial production of innovative cell therapies in India.

Under the agreement, Nucelion, a wholly owned subsidiary of Bharat Biotech, will serve as the technology transfer and clinical- and commercial-stage manufacturing partner for VeGen Bio's lead candidate, VL-2511, a first-in-class dual BCMA/CD19 autologous CAR-T th...